Ichie Kajiwara

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Makoto Sano · 6 shared papers, 2019–2026 · strength 1.01
   • Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
2. Hideaki Ijichi · 6 shared papers, 2019–2026 · strength 1.01
   • Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
3. Yukino Oshima · 5 shared papers, 2020–2026 · strength 0.91
   • Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
4. Tomoaki Itaya · 4 shared papers, 2022–2026 · strength 0.80
   • Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
5. Tomoya Kuramochi · 4 shared papers, 2022–2026 · strength 0.80
   • Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
6. Yoshimi Ichimaru · 5 shared papers, 2019–2024 · strength 0.71
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
   • Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
7. Takahiro Suzuki · 4 shared papers, 2020–2024 · strength 0.61
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
   • Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
8. Atsushi Masamune · 4 shared papers, 2020–2024 · strength 0.61
   • Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
   • Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
   • Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
9. Takahiro Suzuki · 1 shared paper, 2026 · strength 0.30
   • Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
10. Yohei Masugi · 1 shared paper, 2022 · strength 0.13
    • Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
11. Hiroyuki Hao · 1 shared paper, 2020 · strength 0.11
    • Paper Duloxetine improves cancer-associated pain in a mouse model of pancreatic cancer through stimulation of noradrenaline p… DOI 10.1097/j.pain.0000000000001997↗
12. Hiroki Yoshioka · 1 shared paper, 2019 · strength 0.10
    • Paper Indirubin 3'-Oxime Inhibits Migration, Invasion, and Metastasis InVivo in Mice Bearing Spontaneously Occurring Pancreat… DOI 10.1016/j.tranon.2019.08.010↗
13. Shinichi Miyairi · 1 shared paper, 2019 · strength 0.10
    • Paper Indirubin 3'-Oxime Inhibits Migration, Invasion, and Metastasis InVivo in Mice Bearing Spontaneously Occurring Pancreat… DOI 10.1016/j.tranon.2019.08.010↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.